Clostridioides difficile: innovations in target discovery and potential for therapeutic success. (2021)

First Author: Monaghan TM
Attributed to:  LY256: A novel and potent antibiotic for treating Clostridium difficile infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1080/14728222.2021.2008907

PubMed Identifier: 34793686

Publication URI: http://europepmc.org/abstract/MED/34793686

Type: Journal Article/Review

Volume: 25

Parent Publication: Expert opinion on therapeutic targets

Issue: 11

ISSN: 1472-8222